Cardiac Diagnostics

HeartBeam Inc. Honored with 2025 Innovation Award for Pioneering Remote Cardiac Diagnostics

HeartBeam Inc. (NASDAQ: BEAT) has been awarded the 2025 Innovation Award in Remote Cardiac Diagnostics for its FDA-cleared 3D ECG technology, marking a significant advancement in non-clinical cardiac care.